|Chemical and physical data|
|Molar mass||313.445 g·mol−1|
|3D model (JSmol)|
MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA.
Sweden’s public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.
- “MEPIRAPIM”. Cayman Chemical. Retrieved 23 June 2015.
- Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (January 2014). “Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products”. Forensic Toxicology. 32 (1): 105–115. doi:10.1007/s11419-013-0217-2.
- “Cannabinoider föreslås bli klassade som hälsofarlig vara”. Retrieved 29 June 2015.